BioSpace News Archive

Modification Improves Endoscopists’ Ability to Dissect and Ultimately Resect Polyps Without Surgical Intervention

OTTR, the leading provider of solid organ transplant and cellular therapy patient tracking software, presented stakeholders with an opportunity to learn from renowned health care data integration experts at its recent User International Conference.

Agenus Inc. today announced the election of Dr. Allison Jeynes-Ellis to Agenus’ Board of Directors and the appointment of Dr. Jennifer S. Buell to Chief Operating Officer.

Illumina, Inc. today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.

Cardiovascular Systems, Inc. announced today that the first patients in Germany have been treated with its Stealth 360® Peripheral Orbital Atherectomy System (OAS).

A new study by the company titled ‘Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018–2028', has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the long run in the preterm birth diagnostic test kits market.

Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced that the company presented preclinical data regarding the alphalex™ platform’s application to a poly (ADP- ribose) polymerase (PARP) inhibitor.

V920 is the Company’s Investigational Vaccine for Ebola Zaire

Cellectis S.A. (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced its results for the three-month period ended September 30, 2018 and for the nine-month period end September 30, 2018.

OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will present its latest State of the Science Summit™ on diagnosis, management, and treatment of multiple myeloma.